Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities w...
Main Authors: | Faundez, V, De Toma, I, Bardoni, B, Bartesaghi, R, Nizetic, D, de la Torre, R, Kadosh, R, Herault, Y, Dierssen, M, Potier, M-C |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Elsevier
2018
|
פריטים דומים
-
Modeling Fragile X Syndrome in Drosophila
מאת: Małgorzata Drozd, et al.
יצא לאור: (2018-04-01) -
Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
מאת: Alessandra Tempio, et al.
יצא לאור: (2023-04-01) -
Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer
מאת: Thomas Maurin, et al.
יצא לאור: (2018-12-01) -
A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome
מאת: Tovi Anderson, et al.
יצא לאור: (2013-01-01) -
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
מאת: Sara Castagnola, et al.
יצא לאור: (2017-11-01)